Capitol Hill Cancer groups ask for $4.1 billion increase for NIH, $850 million boost for NCI in FY23 May 27, 2022Vol.48 No.21By Alice Tracey
Clinical Roundup NCI study: Cancer death rates among Black people have declined, but disparities remain May 20, 2022Vol.48 No.20
Capitol Hill Bipartisan misgivings: House appropriators chafe at Biden’s proposal to fund ARPA-H at the expense of NIH May 13, 2022Vol.48 No.19By Alice Tracey
Capitol Hill Whither ARPA-H? What can Biden’s agency do that cancer centers can’t? May 06, 2022Vol.48 No.18By Paul Goldberg
Drugs & Targets Portage Biotech, NCI, Stimunity enter cooperative R&D agreement to develop STING agonists and anti-RAGE agents for cancer vaccines April 29, 2022Vol.48 No.17
Conversation with The Cancer LetterFree Ned Sharpless steps down as NCI director April 08, 2022Vol.48 No.14By Matthew Bin Han Ong and Paul Goldberg
White House Biden’s FY23 proposal cuts NCI funds by $199M, while boosting ARPA-H by $4B April 01, 2022Vol.48 No.13By Alice Tracey and Paul Goldberg
NCI Sharpless: You have to be an optimist to be an oncologist April 01, 2022Vol.48 No.13By Matthew Bin Han Ong
